We are grateful to all researchers & scientists worldwide who used our products. It is an honor for us that our products work for you. Following are some of the publications in which Selleck products were used.
A Yeast-Based In Vivo Bioassay to Screen for Class I Phosphatidylinositol 3-Kinase Specific Inhibitors.
J Biomol Screen 2012 17(8):1018-29ZSTK474purchased from Selleck Chemicals.
Defining pathways of spindle checkpoint silencing: functional redundancy between Cdc20 ubiquitination and p31comet.
Mol Biol Cell 2011 22(22):4227-35ZM-447439purchased from Selleck Chemicals.
Signal transducer and activator of transcription 3 (STAT3) and survivin induction by varicella-zoster virus promote replication and skin pathogenesis.
Proc Natl Acad Sci U S A 2012 109(2):600-5YM155purchased from Selleck Chemicals.
YM155 reverses cisplatin resistance in head and neck cancer by decreasing cytoplasmic survivin levels.
Mol Cancer Ther 2012 11(9):1988-98YM155purchased from Selleck Chemicals.
The Survivin Suppressant YM155 Potentiates Chemosensitivity to Gemcitabine in the Human Pancreatic Cancer Cell Line MiaPaCa-2.
Anticancer Res 2012 32(5):1681-8YM155purchased from Selleck Chemicals.
Increased survivin expression contributes to apoptosis-resistance in IPF fibroblasts.
Adv Biosci Biotechnol 2012 3(6A):657-664YM155purchased from Selleck Chemicals.
